Why Amarin Stock Was a Winner Today

Shares of Amarin (NASDAQ: AMRN) closed 3.9% higher on Tuesday, after there was some good news from across the Atlantic Ocean regarding the only product the company has on the market.

That drug, Vascepa, is used to reduce the risk of stroke and heart attacks in patients taking statins for cardiovascular conditions. On Tuesday, the European Commission (EC), the executive branch of the European Union, approved the medication, which is sold under the brand name Vazkepa in that market.

Image source: Getty Images.

Continue reading

Source Fool.com